+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Interferon"

Graves' Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Graves' Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Psoriatic Arthritis - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriatic Arthritis - Pipeline Insight, 2024

  • Clinical Trials
  • February 2024
  • 180 Pages
  • Global
From
Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • February 2024
  • 60 Pages
  • Global
From
Toll-like receptor 9 (TLR-9) Modulator - Pipeline Insight, 2024 - Product Thumbnail Image

Toll-like receptor 9 (TLR-9) Modulator - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 100 Pages
  • Global
From
Ulcerative Colitis (UC) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Ulcerative Colitis (UC) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • August 2023
  • 295 Pages
  • Global
From
Global Central Nervous System Treatment Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global Central Nervous System Treatment Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Global Multiple Sclerosis Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global Multiple Sclerosis Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
North America Lab-on-a-chip and Microarrays (Biochip) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

North America Lab-on-a-chip and Microarrays (Biochip) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 90 Pages
  • North America
From
Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition - Product Thumbnail Image

Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition

  • Report
  • April 2022
  • 400 Pages
  • Global
Masked Antibodies & Cytokines as Prodrugs: A Landscape Analysis of Stakeholders, Technologies, Pipelines, Business and Financing from An Industry Perspective - Product Thumbnail Image

Masked Antibodies & Cytokines as Prodrugs: A Landscape Analysis of Stakeholders, Technologies, Pipelines, Business and Financing from An Industry Perspective

  • Report
  • October 2021
  • 433 Pages
  • Global
From
Neuroprotective Agents: Therapeutic Applications and Global Markets - Product Thumbnail Image

Neuroprotective Agents: Therapeutic Applications and Global Markets

  • Report
  • June 2018
  • 133 Pages
  • Global
From
Global Multiple Sclerosis (MS) Market - Analysis By Drug Class, Route of Administration, Distribution Channel, By Region, By Country (2021 Edition): Market Insights, Pipeline and Forecast with Impact of COVID-19 (2021-2026) - Product Thumbnail Image

Global Multiple Sclerosis (MS) Market - Analysis By Drug Class, Route of Administration, Distribution Channel, By Region, By Country (2021 Edition): Market Insights, Pipeline and Forecast with Impact of COVID-19 (2021-2026)

  • Report
  • December 2021
  • 220 Pages
  • Global
From
Global Latent Tuberculosis Infection (LTBI) Testing Market: Analysis By Type (Tuberculin Skin Test LTBI Testing and Interferon Gamma Released Assay (IGRA) LTBI Testing), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027 - Product Thumbnail Image

Global Latent Tuberculosis Infection (LTBI) Testing Market: Analysis By Type (Tuberculin Skin Test LTBI Testing and Interferon Gamma Released Assay (IGRA) LTBI Testing), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027

  • Report
  • August 2022
  • 193 Pages
  • Global
From
Multiple Sclerosis Drugs Market Global Report 2020-30 - Product Thumbnail Image

Multiple Sclerosis Drugs Market Global Report 2020-30

  • Report
  • April 2020
  • Global
From
Global Autoimmune Disease Therapeutics Market: Analysis By Drug Class By Indication By Region Size & Trends with Impact of Covid-19 and Forecast up to 2025 - Product Thumbnail Image

Global Autoimmune Disease Therapeutics Market: Analysis By Drug Class By Indication By Region Size & Trends with Impact of Covid-19 and Forecast up to 2025

  • Report
  • March 2022
  • 80 Pages
  • Global
From
Hepatitis Therapeutics Market, By Disease Type (Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D, Other Types), Drug Class (Interferon, Monoclonal Antibody, Non-structural protein 5A (NS5A) inhibitors, Others) and Region: Global Forecast to 2027 - Product Thumbnail Image

Hepatitis Therapeutics Market, By Disease Type (Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D, Other Types), Drug Class (Interferon, Monoclonal Antibody, Non-structural protein 5A (NS5A) inhibitors, Others) and Region: Global Forecast to 2027

  • Report
  • June 2021
  • 220 Pages
  • Global
From
Biotechnology Markets in China - Product Thumbnail Image

Biotechnology Markets in China

  • Report
  • June 2023
  • 256 Pages
  • China
From
Cutaneous Lupus Erythematosus - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Cutaneous Lupus Erythematosus - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 164 Pages
  • Global
From
JAK inhibitors - Competitive Landscape, 2023 - Product Thumbnail Image

JAK inhibitors - Competitive Landscape, 2023

  • Report
  • April 2023
  • 180 Pages
  • Global
From
Interferon - Biosimilar Insight, 2022 - Product Thumbnail Image

Interferon - Biosimilar Insight, 2022

  • Report
  • January 2022
  • 70 Pages
  • Global
From
Loading Indicator

Interferon is a type of biotechnology used to treat a variety of diseases, including cancer, hepatitis, and multiple sclerosis. It is a naturally occurring protein produced by the body in response to viral infections. Interferon works by stimulating the immune system to fight off the virus, and can also be used to reduce inflammation and slow the growth of tumors. Interferon is available in both natural and synthetic forms, and is used in a variety of treatments. It is often used in combination with other drugs, such as chemotherapy, to increase the effectiveness of the treatment. Interferon is also used in gene therapy, where it is used to introduce new genes into cells to treat genetic diseases. The interferon market is highly competitive, with many companies offering different types of interferon products. Some of the major players in the market include Roche, Merck, Novartis, and GlaxoSmithKline. These companies are constantly developing new products and technologies to improve the effectiveness of interferon treatments. Show Less Read more